Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 9Thoracic 3Head & Neck 3Gynecologic 3Gastrointestinal 3Tumor-Agnostic 2Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1Lymphoid 1Genitourinary 1Classical hematology 1CNS 1

Conditions

Neoplasms 2

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Population Groups × Tumor-Agnostic × Clear all
NCT06825429 2025-02-13

Group Exercise in Cancer Patients Under Active Treatment: Feasibility Pilot Study.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase NA Not yet recruiting
50 enrolled
Tumor-Agnostic

Neoplasms

NCT02550925 2020-03-26

Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors

University of Colorado, Boulder

Phase NA Completed
139 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡